Literature DB >> 21358726

Deal watch: Amgen buys oncolytic virus company.

.   

Abstract

Mesh：

Year:  2011        PMID： 21358726     DOI： 10.1038/nrd3391

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.

Authors:  Neil N Senzer; Howard L Kaufman; Thomas Amatruda; Mike Nemunaitis; Tony Reid; Gregory Daniels; Rene Gonzalez; John Glaspy; Eric Whitman; Kevin Harrington; Howard Goldsweig; Tracey Marshall; Colin Love; Robert Coffin; John J Nemunaitis
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544
  1 in total
  1 in total

1.  Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs.

Authors:  K-X Zhang; Y Matsui; C Lee; O Osamu; L Skinner; J Wang; A So; P S Rennie; W W Jia
Journal:  Gene Ther       Date:  2016-02-23       Impact factor: 5.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.